Adjustment Disorders

Clinical Snapshot

Adjustment disorder is a stress-related condition in which emotional or behavioural symptoms develop within 3 months of an identifiable psychosocial stressor — job loss, relationship breakdown, a new medical diagnosis, financial strain, relocation, or a similar life change — and cause distress that is clearly out of proportion to the stressor, or significant impairment in social, occupational, or other important functioning.^[1] By definition the presentation does not meet full diagnostic criteria for another mental disorder such as major depressive disorder, generalized anxiety disorder, or post-traumatic stress disorder, and it is not simply an expected, culturally sanctioned response to bereavement. Once the stressor and its consequences have ended, symptoms are not expected to persist beyond an additional 6 months — a presentation that does persist, or that has always looked more like a full depressive, anxiety, or trauma-related disorder, needs to be re-diagnosed and managed as that disorder instead, not treated indefinitely as adjustment disorder.^[1]

The single most important prescribing point in this chapter: brief, structured psychotherapy — not an antidepressant — is the first-line treatment. The evidence specifically supporting antidepressant use in adjustment disorder is low-to-very-low quality,^[2] and a pharmacotherapy-focused review has concluded that medication use has not been adequately substantiated as a treatment for adjustment disorder itself.^[3] Despite being definitionally milder than major depressive disorder, adjustment disorder carries a real, elevated risk of suicidal ideation, self-harm, and suicide, and every assessment must include explicit safety screening.^[4]

Recognize the Condition

DSM-5-TR diagnostic criteria

A. Emotional or behavioural symptoms developing in response to an identifiable stressor(s), occurring within 3 months of the onset of the stressor(s).
B. These symptoms or behaviours are clinically significant, as shown by 1 or both of: marked distress that is out of proportion to the severity or intensity of the stressor, taking into account external context and cultural factors; or significant impairment in social, occupational, or other important areas of functioning.
C. The stress-related disturbance does not meet criteria for another mental disorder and is not merely an exacerbation of a pre-existing mental disorder.
D. The symptoms do not represent normal bereavement and are not better explained by prolonged grief disorder.
E. Once the stressor or its consequences have terminated, the symptoms do not persist for more than an additional 6 months.

^[1]

Subtypes

Specifier	Predominant presentation
With depressed mood	Low mood, tearfulness, and feelings of hopelessness predominate.
With anxiety	Nervousness, worry, and difficulty concentrating predominate (or separation fears, in children).
With mixed anxiety and depressed mood	A combination of both symptom sets.
With disturbance of conduct	Behaviour that violates the rights of others or age-appropriate societal norms — truancy, vandalism, reckless driving, fighting.
With mixed disturbance of emotions and conduct	A combination of emotional symptoms and conduct disturbance.
Unspecified	A maladaptive reaction not classifiable under the other specifiers — for example, social withdrawal or physical complaints without a clear depressed, anxious, or conduct-disturbance pattern.

Typical stressors

Any identifiable event or change can qualify — adjustment disorder is not restricted to a life-threatening trauma the way PTSD is. Common triggers include job loss or workplace conflict, relationship breakdown or divorce, a new medical diagnosis or health scare, financial difficulty, immigration or relocation, retirement, a child leaving home, or an acute family crisis. The stressor can be a single event, multiple events, or a recurrent or continuous stressor (an ongoing illness, an unstable relationship), and can affect an individual, a family, or a whole community.

Presentation pattern

Symptoms are, by definition, subsyndromal compared with a full depressive or anxiety episode — fewer symptoms, and less severe — which is part of what distinguishes adjustment disorder from major depressive disorder rather than being simply a matter of degree.^[5] A patient typically presents with low mood, anxiety, irritability, tearfulness, sleep disturbance, poor concentration, or a change in behaviour that is clearly tied in time to the stressor and that the patient (or family) can usually connect directly to the triggering event.

Risk Factors

Prior psychiatric history, including previous depressive, anxiety, or adjustment-related episodes.
Limited coping skills, or a rigid, all-or-nothing style of appraising stressors.
Limited social support, or a stressor that itself disrupts the patient's usual support network (relocation, relationship breakdown).
Concurrent or cumulative life stressors occurring close together, rather than a single isolated event.
Chronic medical illness, or a new and threatening medical diagnosis.
Financial or housing insecurity.
Personality factors that increase vulnerability to stress, though adjustment disorder occurs across the full range of personality styles and is not restricted to any one profile.
Younger age is associated with a relatively higher rate of adjustment disorder diagnosis in some clinical settings, though the condition occurs across the lifespan.

Red Flags & Refer

Escalate to urgent assessment for any of the following:

Active suicidal ideation, a stated plan, intent, or access to means, or any current self-harm — assess immediately. Adjustment disorder carries a real and clinically significant risk of self-harm and suicide, including in patients presenting to emergency and general medical settings; do not treat the diagnosis itself as reassuring simply because it is definitionally milder than major depressive disorder.^[4]
Psychotic symptoms (hallucinations, delusions) accompanying the presentation — not consistent with adjustment disorder and needs its own assessment.
Symptoms that, on closer assessment, actually meet full criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or post-traumatic stress disorder — re-diagnose and manage per that disorder's own chapter rather than continuing to treat as adjustment disorder.^[1]
Evidence of an unsafe current situation — intimate partner violence, abuse, or an ongoing safety threat — requiring safety planning rather than symptom-focused treatment alone.
Severe functional impairment (inability to work, care for dependents, or maintain basic self-care) out of keeping with a straightforward adjustment reaction.
Symptoms persisting more than 6 months after the stressor and its consequences have genuinely resolved — this no longer fits the adjustment disorder definition and needs diagnostic reassessment.^[1]
A conduct-disturbance presentation with behaviour that risks harm to the patient or others (reckless driving, aggression, substance misuse) — needs a broader risk assessment, not symptom-focused counselling alone.

Assessment & Diagnosis

History

Identify the specific stressor(s) and confirm the time course: symptom onset within 3 months of the stressor, and — if the stressor has already resolved — how long ago that was.
Characterize the predominant symptoms (mood, anxiety, conduct) and their functional impact on work, relationships, and daily activities.
Ask directly about suicidal ideation, self-harm, and current safety at every assessment, regardless of how mild the presentation initially appears.^[4]
Screen specifically for symptoms that would instead meet criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or PTSD (if the stressor involved actual or threatened death, serious injury, or sexual violence) — see the differentiation table below.
Ask about substance use, which commonly increases during a stressful period and can itself worsen or mimic adjustment symptoms.
Confirm the presentation is not a normal, proportionate, or culturally expected response to bereavement or to the stressor itself — distress that is proportionate to a genuinely severe stressor, and improving over time, is not on its own a disorder.

Differentiating adjustment disorder from other stress-related presentations

Feature	Adjustment disorder	Major depressive disorder / generalized anxiety disorder	PTSD / acute stress disorder	Normal stress response or grief
Qualifying stressor	Any identifiable stressor	Not required — can arise without an identifiable trigger	Required — actual or threatened death, serious injury, or sexual violence specifically	Any life event, including bereavement
Symptom threshold	Distress out of proportion to the stressor, or functional impairment — but does not meet the full symptom-count criteria for another disorder	Meets full DSM-5-TR symptom-count and duration criteria for that disorder	Meets full DSM-5-TR symptom-cluster criteria for that disorder	Proportionate to the event; does not cause the marked distress or impairment a disorder diagnosis requires
Course	Resolves within 6 months of the stressor (or its consequences) ending	Can persist independent of any stressor resolving	Can persist independent of any stressor resolving	Improves gradually and naturally over time
Management implication	Brief, present-centered psychotherapy first; time-boxed, symptom-targeted medication only if genuinely needed (this chapter)	Manage per the Depression or Anxiety Disorders chapter, including standard antidepressant pharmacotherapy where indicated	Manage per the Post-traumatic Stress Disorder chapter	Support and monitor; formal treatment is not usually indicated

Screening and monitoring tools

Tool	Purpose
PHQ-9 / GAD-7	Useful for quantifying depressive or anxious symptom severity and tracking change over time when the depressed-mood or anxiety specifier predominates, and for confirming the symptom burden falls short of a full depressive or anxiety episode.
Adjustment Disorder–New Module (ADNM-20) / International Adjustment Disorder Questionnaire (IADQ)	Adjustment-disorder-specific self-report instruments used in some specialist and research settings to support diagnosis and track symptom change; not required for routine primary care or pharmacy-based assessment.

Physical examination and investigations

Adjustment disorder has no diagnostic laboratory test. Consider basic investigations (thyroid function tests, CBC, glucose) when the history or examination raises the possibility of an underlying medical cause for the mood, anxiety, or behavioural symptoms — for example new fatigue, weight change, or cognitive symptoms alongside the stress-related complaint — rather than as a routine requirement for every presentation.

Treatment Targets

Reduce symptoms (depressed mood, anxiety, conduct disturbance) tied to the identifiable stressor.
Restore social, occupational, and daily functioning to the patient's baseline.
Support adaptive coping and problem-solving specific to the stressor, rather than simply suppressing symptoms.
Identify and manage suicide risk and any unsafe situation.
Prevent progression to a full major depressive, anxiety, or trauma-related disorder.
Avoid unnecessary, prolonged pharmacotherapy for a condition that is, by definition, time-limited.

Choose Initial Treatment

Direct treatment rule

1st line brief, structured, stressor-focused psychotherapy — cognitive behavioural therapy (CBT) or problem-solving therapy — offered as the primary treatment. These approaches directly target the patient's appraisal of, and coping response to, the specific stressor, and are supported by clinical consensus even though the adjustment-disorder-specific trial evidence base remains relatively small.^[2]

Reasonable for mild presentations a period of watchful waiting with scheduled, close follow-up (for example, in 1-2 weeks) is appropriate when symptoms are mild, functional impairment is limited, and the patient has reasonable coping resources and support — provided suicide risk has been screened and is negative.^[5]

Do not default to an antidepressant as first-line treatment the evidence specifically supporting antidepressants for adjustment disorder — as opposed to for major depressive disorder or an anxiety disorder — is low-to-very-low quality and has not been adequately substantiated.^[2]^[3] Reserve antidepressant therapy for a patient whose presentation is reassessed and found to actually meet full criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or PTSD, and then prescribe per that specific chapter — not as an adjustment-disorder-specific recommendation.

Limited, time-boxed adjunct pharmacotherapy reserved for acute, significantly impairing anxiety or insomnia that has not adequately responded to non-pharmacologic measures, used for the shortest effective duration (days to at most a few weeks) with an explicit review or stop date set at initiation — never as an open-ended or default component of treatment. See Pharmacologic Treatment Options for the specific short-term options and their sequencing.

Avoid routine or extended benzodiazepine use if a benzodiazepine is used at all, restrict it to brief, severe distress, and avoid it altogether in a patient with any current or past substance use disorder risk.

Non-Pharmacologic Treatment

First-line psychotherapy

Recommended approaches

Cognitive behavioural therapy (CBT)

Addresses unhelpful appraisals of the stressor and the patient's response to it; the most studied psychotherapy for adjustment disorder.^[2]

Problem-solving therapy

A brief, structured approach that teaches the patient a stepwise process for defining the problem created by the stressor, generating and evaluating options, and implementing a solution. Well suited to a genuinely time-limited, stressor-linked presentation and deliverable in primary care or a similar accessible setting by a trained provider.

Supportive and present-centered counselling

Focuses on validating the patient's distress, reinforcing existing coping strategies, and problem-solving around the immediate stressor, without requiring formal manualized therapy — a reasonable option when structured CBT or problem-solving therapy is not readily accessible.

Other supported approaches

Brief psychodynamic therapy, family therapy, and interpersonal therapy also have some supporting evidence and may be preferred depending on the nature of the stressor (a family conflict, a relationship breakdown) and patient preference.^[2]

Self-management and lifestyle measures

Maintain regular routines, sleep schedule, and physical activity where possible — disruption of routine often compounds the stress response.
Preserve and actively use existing social support rather than withdrawing from it.
Sleep hygiene measures are the first step for sleep disturbance, before considering any sleep-targeted medication.
For a workplace-related stressor, workplace accommodations or an employee assistance program referral can directly address the stressor itself, not just the symptoms it produced.

Watchful waiting

For a mild presentation with good baseline coping and support, watchful waiting with a scheduled, close follow-up visit is a legitimate management strategy — many patients improve as they adapt to the stressor without needing formal psychotherapy or medication.^[5] This is not the same as no follow-up: suicide risk should still be screened at the initial visit and reassessed at the follow-up.

Pharmacologic Treatment Options

Drug / intervention	Role	Dose / use	Important adverse effects	Teaching points
Hydroxyzine Special situation	Short-term, non-benzodiazepine option for acute, impairing anxiety	25-50 mg PO as needed; usual maximum 100 mg/day in divided doses	Sedation, dry mouth, blurred vision	Preferred over a benzodiazepine as the initial short-term option given no dependence or misuse potential. Still time-limited — use for the shortest effective duration and reassess rather than renewing by default.
Lorazepam Special situation	Very short-term option for acute, severe anxiety not controlled by non-benzodiazepine measures	0.5-1 mg PO as needed; use for days, not weeks	Sedation, cognitive impairment, ataxia and fall risk (especially in older adults)	Avoid in any patient with current or past substance use disorder risk. Set an explicit stop or taper date at initiation; do not renew without reassessment.
Zopiclone Special situation	Short-term option for acute, significant insomnia not responding to sleep hygiene measures	3.75-7.5 mg PO at bedtime; limit to a few days to 2 weeks	Unpleasant taste, sedation, dizziness	Non-pharmacologic sleep measures remain first-line. Reassess the need at every renewal and avoid extending beyond the initial short course.
Antidepressant (SSRI, SNRI, or other agent) Not recommended as adjustment-disorder therapy	Not a default or adjustment-disorder-specific treatment	Not prescribed for adjustment disorder itself	Not applicable	Evidence for antidepressants specifically in adjustment disorder is low-to-very-low quality. Use only if reassessment confirms the presentation now meets full criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or PTSD, and then prescribe per that disorder's own chapter and dosing.

Evidence gap: no specific antidepressant is recommended here for adjustment disorder itself. Current systematic-review evidence for antidepressants specifically in this condition is low-to-very-low quality,^[2] and a 2022 pharmacotherapy-focused review concluded medication use in adjustment disorder remains insufficiently substantiated.^[3] If pharmacotherapy for a mood or anxiety syndrome is genuinely needed, confirm first whether the presentation actually meets criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or PTSD, and prescribe from that chapter instead.

Special Populations

Pregnancy and postpartum

Pregnancy, pregnancy loss, and the early postpartum period are common triggers for adjustment disorder. Non-pharmacologic treatment remains preferred throughout. Avoid benzodiazepines in pregnancy and while breastfeeding where possible, given sedation and, with regular use, neonatal withdrawal risk; if a genuine mood or anxiety disorder emerges rather than a time-limited adjustment reaction, manage medication choice per the Depression or Anxiety Disorders chapter rather than this one.

Children and adolescents

Adjustment disorder is common in this age group, often triggered by family conflict, parental separation, or a school-related stressor, and frequently presents with the conduct-disturbance or mixed specifier. Family-involved therapy and school liaison are often central to treatment. The short-term pharmacotherapy options and doses in this chapter are adult doses; do not extrapolate them to children or adolescents — refer to child/adolescent psychiatry if medication is being considered.

Older adults

Retirement, bereavement, relocation (including a move to long-term care), and new or worsening chronic illness are common triggers. Use particular caution with any sedating or anticholinergic option (hydroxyzine, benzodiazepines, zopiclone) given increased fall risk and, with benzodiazepines specifically, an increased risk of cognitive impairment and delirium in this population — favour non-pharmacologic treatment even more strongly than in a younger adult.

Substance use disorder

Avoid benzodiazepines given real misuse and dependence risk on top of the lack of adjustment-disorder-specific efficacy evidence; a non-benzodiazepine option or non-pharmacologic measures are preferred if a short-term anxiolytic is genuinely needed.

Occupational and disability contexts

Adjustment disorder is a common diagnosis in workers' compensation and short-term disability assessments. Document the specific stressor, functional impact, and expected time course clearly, and involve workplace accommodation or an employee assistance program where relevant — addressing the occupational stressor directly is often more effective than symptom-focused treatment alone.

Monitoring & Follow-Up

Schedule close follow-up (for example, in 1-2 weeks) after the initial assessment, particularly if watchful waiting or a brief psychotherapy referral is the plan — do not simply wait for the patient to return.
Reassess suicide risk and safety at every follow-up visit, not only at the initial assessment.
Track symptom trajectory against the stressor timeline: symptoms should be trending toward improvement, particularly once the stressor itself has resolved.
If a short-term anxiolytic or sleep aid was started, confirm the stop or taper date set at initiation is being followed, and do not renew without a specific reassessment.
Reassess the diagnosis itself if symptoms have not meaningfully improved by around 3 months, and definitely if they persist more than 6 months after the stressor and its consequences have resolved — by definition, this no longer fits adjustment disorder.^[1]
Watch specifically for evolution into a full major depressive episode, generalized anxiety disorder, panic disorder, or PTSD, and transition management to that specific pathway if criteria are met.

Treatment Failure / Next Step

Confirm the diagnosis is still correct — reassess whether the presentation has evolved to meet full criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or PTSD, and switch to that disorder's management pathway if so.
Confirm psychotherapy was actually offered and accessed, not just recommended — access barriers (cost, wait times, stigma) are a common reason for apparent non-response.
Reassess whether the identifiable stressor is ongoing or has changed — an unresolved or worsening stressor (continuing workplace conflict, an unresolved medical issue) may need its own direct intervention before symptom-focused treatment can succeed.
If a short-term anxiolytic or sleep aid was used, confirm it was genuinely time-boxed and reassess whether continuing it is still appropriate, rather than allowing it to continue by default.
Screen again for a substance use disorder or another untreated comorbidity that may be maintaining symptoms.
If symptoms remain significant and impairing despite an adequate trial of brief psychotherapy and confirmed diagnosis, refer to psychiatry or psychology for a more intensive or structured intervention rather than escalating pharmacotherapy on an adjustment-disorder basis.

Common Errors to Avoid

Starting an antidepressant as a default, first-line treatment for adjustment disorder without first offering brief psychotherapy — the evidence does not support this as routine practice.^[2]
Treating adjustment disorder as inherently low-risk and skipping suicide risk screening because the diagnosis is definitionally milder than major depressive disorder.^[4]
Continuing a short-term anxiolytic or sleep aid past its intended stop date without an explicit reassessment.
Using a benzodiazepine in a patient with current or past substance use disorder risk.
Failing to reassess the diagnosis when symptoms persist beyond 6 months after the stressor and its consequences have resolved.
Missing an evolving major depressive episode, anxiety disorder, or PTSD by continuing to manage the presentation as adjustment disorder indefinitely.
Diagnosing adjustment disorder in a presentation that is actually a normal, proportionate response to a genuinely severe stressor, or normal/culturally expected grief.
Extrapolating adult short-term pharmacotherapy doses to children or adolescents.

Clinical Decision Algorithm

Diagnosis and initial treatment selection

Emotional or behavioural symptoms developing within 3 months of an identifiable stressor

Screen for suicidal ideation, self-harm, and current safety — at this visit and every follow-up

Safety concern identified

Manage the acute safety risk first; escalate per Red Flags & Refer

No immediate safety concern

Confirm criteria: distress out of proportion to the stressor or functional impairment, not better explained by another disorder, not normal bereavement

Meets full criteria for MDD, GAD, panic disorder, or PTSD instead

Diagnose and manage per that disorder's own chapter, not as adjustment disorder

Meets adjustment disorder criteria

Diagnose adjustment disorder

Mild symptoms, adequate coping and support

Watchful waiting with close follow-up (about 1-2 weeks) is reasonable

Moderate-severe symptoms or significant impairment

Offer brief, structured psychotherapy (CBT or problem-solving therapy) as 1st-line treatment

Limited role of adjunct pharmacotherapy

Acute, significantly impairing anxiety or insomnia despite non-pharmacologic measures and a psychotherapy referral

Assess for substance use disorder risk and other contraindications

No substance use disorder risk

Use a short-term, non-benzodiazepine option first (e.g., hydroxyzine for anxiety, or a short-term hypnotic for insomnia)

Inadequate control of severe, acute anxiety

A brief benzodiazepine course may be considered — days, not weeks

Adequately controlled

Continue the non-benzodiazepine option only, for the shortest effective duration

Set an explicit stop or taper date at initiation; reassess at the next follow-up rather than renewing by default

Substance use disorder risk present

Avoid benzodiazepines; use non-pharmacologic measures and a non-benzodiazepine option only, with close follow-up

Reassessment at the 6-month stressor-resolution point

Stressor and its consequences have resolved

Symptoms resolve within 6 months of resolution

Consistent with adjustment disorder's expected course — taper support as symptoms improve

Symptoms persist beyond 6 months of resolution

No longer fits the adjustment disorder definition — reassess for major depressive disorder, generalized anxiety disorder, PTSD, or another primary diagnosis

Drug Tables

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Non-benzodiazepine anxiolytic (preferred initial short-term option)

First choice when a short-term, time-boxed medication is genuinely needed for acute, impairing anxiety.

Drug	Dosage	Adverse effects	Drug interactions	Comments
Hydroxyzine	Usual: 25-50 mg PO as needed Maximum: Up to 100 mg/day in divided doses	Sedation, dry mouth, blurred vision, dizziness	Additive CNS depression with alcohol, opioids, or other sedatives; additive anticholinergic burden with other anticholinergic drugs	No dependence or misuse potential, unlike a benzodiazepine. Use for the shortest effective duration; reassess rather than renewing by default.

Benzodiazepine (short-term, special-situation use only)

Reserve for acute, severe anxiety not adequately controlled by non-benzodiazepine and non-pharmacologic measures. Not for routine or extended use, and not recommended at all in a patient with current or past substance use disorder risk.

Drug	Dosage	Adverse effects	Drug interactions	Comments
Lorazepam	Usual: 0.5-1 mg PO as needed	Sedation, cognitive impairment, ataxia and fall risk (especially in older adults)	Additive CNS depression with alcohol, opioids, or other sedatives	Set an explicit stop or taper date at initiation. Use for days, not weeks.
Oxazepam	Usual: 10-15 mg PO as needed	Sedation, ataxia and fall risk (especially in older adults)	Additive CNS depression with alcohol, opioids, or other sedatives	An alternative short-acting benzodiazepine with no active metabolites, which can be preferable in hepatic impairment or in older adults if a benzodiazepine is genuinely needed.

Short-term hypnotic (acute insomnia only)

Non-pharmacologic sleep measures are the first step; reserve a short-term hypnotic for acute, significant insomnia not responding to those measures.

Drug	Dosage	Adverse effects	Drug interactions	Comments
Zopiclone	Usual: 3.75-7.5 mg PO at bedtime	Unpleasant or metallic taste, sedation, dizziness	Additive CNS depression with alcohol or other sedatives; levels increased by strong CYP3A4 inhibitors (clarithromycin, ketoconazole) and decreased by strong CYP3A4 inducers (rifampin, carbamazepine)	Limit to a few days to 2 weeks; reassess before any renewal rather than continuing by default.

Deliberately not listed here with a dose: antidepressants (SSRIs, SNRIs, or other agents). Current systematic-review evidence for antidepressants specifically in adjustment disorder is low-to-very-low quality,^[2] and a pharmacotherapy-focused review concluded that medication use for adjustment disorder itself remains insufficiently substantiated.^[3] If a patient's presentation is reassessed and found to meet full criteria for major depressive disorder, generalized anxiety disorder, panic disorder, or PTSD instead, prescribe an antidepressant per that specific chapter — not as an adjustment-disorder-specific recommendation.

References

Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) — American Psychiatric Association. Washington (DC): American Psychiatric Publishing; 2022
A Systematic Review of Psychological and Pharmacological Treatments for Adjustment Disorder in Adults — Journal of Traumatic Stress (O'Donnell ML, Metcalf O, Watson L, Phelps A, Varker T). J Trauma Stress 2018;31(3):321-331
What are the pharmacotherapeutic options for adjustment disorder? — Expert Opinion on Pharmacotherapy (Hoffman J, Stein DJ). Expert Opin Pharmacother 2022;23(6):643-646
Adjustment Disorder and Suicidal Behaviours Presenting in the General Medical Setting: A Systematic Review — International Journal of Environmental Research and Public Health (Fegan J, Doherty AM). Int J Environ Res Public Health 2019;16(16):2967
Depression: Diagnosis — Centre for Addiction and Mental Health (CAMH). CAMH, Professionals — Treating Conditions and Disorders

Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.